Related Experiment Videos
Are actual driving tests necessary for evaluating drug safety?
1Institute for Drugs, Safety and Behaviour, University of Limburg, Maastricht, Holland.
International Clinical Psychopharmacology
|May 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers.
Journal of psychopharmacology (Oxford, England)·2012
Survival and nutritional requirements of three bacteria isolated from ultrapure water.
Journal of industrial microbiology & biotechnology·2002
Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens.
Journal of clinical psychopharmacology·2000
Venlafaxine's effects on healthy volunteers' driving, psychomotor, and vigilance performance during 15-day fixed and incremental dosing regimens.
Journal of clinical psychopharmacology·1998
Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.
The Journal of allergy and clinical immunology·1998
Lithium and GLP-1-based therapies in bipolar disorder: an emerging pharmacovigilance signal and monitoring considerations.
International clinical psychopharmacology·2026
Effectiveness and safety of long-acting aripiprazole 960 mg: preliminary findings from a prospective real-world observational study.
International clinical psychopharmacology·2026
Critical reassessment of manic and psychotic episodes related to levetiracetam: a systematic review of published case reports.
International clinical psychopharmacology·2026
Methylphenidate treatment in adults with comorbid attention-deficit/hyperactivity disorder and borderline personality disorder: a prospective longitudinal study.
International clinical psychopharmacology·2026
Association between anxious depression and clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD).
International clinical psychopharmacology·2026
Drug development in autism spectrum disorder: genetic heterogeneity, failed trials, and the case for stratified pharmacotherapy.
International clinical psychopharmacology·2026
Risk of Schizophrenia Spectrum Disorders Following Parkinson's Disease: A Nationwide Population-Based Cohort Study.
Psychiatry investigation·2026
Breaking the 1% unbound threshold: an IQ consortium whitepaper on the evaluation of plasma protein binding of highly bound compounds.
Drug metabolism and disposition: the biological fate of chemicals·2026
A Systematic Review of Long-term Safety Outcomes of Ketamine and Esketamine in Patients with Treatment-resistant Depression.
Psychotherapy and psychosomatics·2026
Acute Colonic Pseudo-obstruction Following Massive Bupropion Overdose.
Journal of investigative medicine high impact case reports·2026